Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


18.09.2017

1 AJR Am J Roentgenol
1 Am J Pathol
1 Am J Respir Crit Care Med
1 Ann Surg
5 Ann Thorac Surg
1 Br J Cancer
4 Cancer
1 Cancer Chemother Pharmacol
2 Eur J Cancer
1 Int J Cancer
2 J Clin Oncol
1 J Thorac Cardiovasc Surg
1 Lancet Oncol
1 Mol Carcinog
2 Nat Med
1 Oncol Rep
6 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. PINSKY PF, Gierada DS, Nath PH, Munden R, et al
    Lung Cancer Risk Associated With New Solid Nodules in the National Lung Screening Trial.
    AJR Am J Roentgenol. 2017 Sep 12:1-6. doi: 10.2214/AJR.17.18252.
    PubMed     Text format     Abstract available


    Am J Pathol

  2. DONGRE A, Clements D, Fisher AJ, Johnson SR, et al
    Cathepsin K in Lymphangioleiomyomatosis: LAM Cell-Fibroblast Interactions Enhance Protease Activity by Extracellular Acidification.
    Am J Pathol. 2017;187:1750-1762.
    PubMed     Text format     Abstract available


    Am J Respir Crit Care Med

  3. TANNER NT, Dai L, Bade BC, Gebregziabher M, et al
    Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.
    Am J Respir Crit Care Med. 2017;196:602-608.
    PubMed     Text format     Abstract available


    Ann Surg

  4. PREDINA JD, Newton AD, Keating J, Barbosa EM Jr, et al
    Intraoperative Molecular Imaging Combined With Positron Emission Tomography Improves Surgical Management of Peripheral Malignant Pulmonary Nodules.
    Ann Surg. 2017;266:479-488.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  5. XUE Z, Wu F, Pierson KE, Mara KC, et al
    Survival in Surgical and Nonsurgical Patients With Superior Sulcus Tumors.
    Ann Thorac Surg. 2017;104:988-997.
    PubMed     Text format     Abstract available

  6. MURAKAMI J, Ueda K, Tanaka T, Kobayashi T, et al
    The Validation of a No-Drain Policy After Thoracoscopic Major Lung Resection.
    Ann Thorac Surg. 2017;104:1005-1011.
    PubMed     Text format     Abstract available

  7. OKUMURA T, Boku N, Hishida T, Ohde Y, et al
    Surgical Outcome and Prognostic Stratification for Pulmonary Metastasis From Colorectal Cancer.
    Ann Thorac Surg. 2017;104:979-987.
    PubMed     Text format     Abstract available

  8. BRUNELLI A, Dinesh P, Woodcock-Shaw J, Littlechild D, et al
    Ninety-Day Mortality After Video-Assisted Thoracoscopic Lobectomy: Incidence and Risk Factors.
    Ann Thorac Surg. 2017;104:1020-1026.
    PubMed     Text format     Abstract available

  9. SUZUKI S, Sakurai H, Masai K, Asakura K, et al
    A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size.
    Ann Thorac Surg. 2017;104:1027-1032.
    PubMed     Text format     Abstract available


    Br J Cancer

  10. KLIMOV S, Rida PC, Aleskandarany MA, Green AR, et al
    Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers.
    Br J Cancer. 2017;117:826-834.
    PubMed     Text format     Abstract available


    Cancer

  11. LAMBROS L, Guibourg B, Uguen A
    Costs of ALK, ROS1, EGFR, and KRAS testing in non-small cell lung cancer: About different strategies in France.
    Cancer. 2017 Sep 11. doi: 10.1002/cncy.21919.
    PubMed     Text format    

  12. TRONCONE G
    Reply to Costs of ALK, ROS1, EGFR, and KRAS testing in non-small cell lung cancer: About different strategies in France.
    Cancer. 2017 Sep 11. doi: 10.1002/cncy.21918.
    PubMed     Text format    

  13. JAGAI JS, Messer LC, Rappazzo KM, Gray CL, et al
    County-level cumulative environmental quality associated with cancer incidence.
    Cancer. 2017;123:2901-2908.
    PubMed     Text format     Abstract available

  14. MOORE KN, Borghaei H, O'Malley DM, Jeong W, et al
    Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor alpha-targeting antibody-drug conjugate, in patients with solid tumors.
    Cancer. 2017;123:3080-3087.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  15. IKEZAWA Y, Asahina H, Oizumi S, Watanabe M, et al
    A randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002).
    Cancer Chemother Pharmacol. 2017 Sep 13. doi: 10.1007/s00280-017-3432.
    PubMed     Text format     Abstract available


    Eur J Cancer

  16. LIN PL, Wu TC, Wu DW, Wang L, et al
    An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non-small cell lung cancer via persistent activation of ERK signalling.
    Eur J Cancer. 2017;85:95-105.
    PubMed     Text format     Abstract available

  17. MCWILLIAM A, Kennedy J, Hodgson C, Vasquez Osorio E, et al
    Radiation dose to heart base linked with poorer survival in lung cancer patients.
    Eur J Cancer. 2017;85:106-113.
    PubMed     Text format     Abstract available


    Int J Cancer

  18. BRYANT JL, Gieling RG, Meredith SL, Allen TJ, et al
    Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer.
    Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31042.
    PubMed     Text format     Abstract available


    J Clin Oncol

  19. O'NEILL AF, Towbin AJ, Krailo MD, Xia C, et al
    Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.
    J Clin Oncol. 2017 Sep 11:JCO2017735654. doi: 10.1200/JCO.2017.73.5654.
    PubMed     Text format     Abstract available

  20. KUBOTA K, Yoshioka H, Oshita F, Hida T, et al
    Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Motesanib (AMG-706) in Combination With Paclitaxel and Carboplatin in East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2017 Sep 13:JCO2017727297. doi: 10.1200/JCO.2017.72.7297.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  21. CORNWELL LD, Echeverria AE, Samuelian J, Mayor J, et al
    Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
    J Thorac Cardiovasc Surg. 2017 Aug 16. pii: S0022-5223(17)31718.
    PubMed     Text format     Abstract available


    Lancet Oncol

  22. DEL PAGGIO JC, Sullivan R, Schrag D, Hopman WM, et al
    Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks.
    Lancet Oncol. 2017;18:887-894.
    PubMed     Text format     Abstract available


    Mol Carcinog

  23. ZHAO H, Zhang D, Yang L, Wang E, et al
    p0071 interacts with E-cadherin in the cytoplasm so as to promote the invasion and metastasis of non-small cell lung cancer.
    Mol Carcinog. 2017 Sep 12. doi: 10.1002/mc.22734.
    PubMed     Text format     Abstract available


    Nat Med

  24. MAYORCA-GUILIANI AE, Madsen CD, Cox TR, Horton ER, et al
    ISDoT: in situ decellularization of tissues for high-resolution imaging and proteomic analysis of native extracellular matrix.
    Nat Med. 2017;23:890-898.
    PubMed     Text format     Abstract available

  25. XUE Y, Martelotto L, Baslan T, Vides A, et al
    An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
    Nat Med. 2017;23:929-937.
    PubMed     Text format     Abstract available


    Oncol Rep

  26. HAN Z, Zhou X, Li S, Qin Y, et al
    Inhibition of miR-23a increases the sensitivity of lung cancer stem cells to erlotinib through PTEN/PI3K/Akt pathway.
    Oncol Rep. 2017 Sep 4. doi: 10.3892/or.2017.5938.
    PubMed     Text format     Abstract available


    PLoS One

  27. LYNCH CM, van Berkel VH, Frieboes HB
    Application of unsupervised analysis techniques to lung cancer patient data.
    PLoS One. 2017;12:e0184370.
    PubMed     Text format     Abstract available

  28. CAI NL, Lau ATY, Yu FY, Wu DD, et al
    Purification and characterization of a highly specific polyclonal antibody against human extracellular signal-regulated kinase 8 and its detection in lung cancer.
    PLoS One. 2017;12:e0184755.
    PubMed     Text format     Abstract available

  29. SHEN Z, Wang H, Xi W, Deng X, et al
    Multi-phase simultaneous segmentation of tumor in lung 4D-CT data with context information.
    PLoS One. 2017;12:e0178411.
    PubMed     Text format     Abstract available

  30. KOO HJ, Kim MY, Koo JH, Sung YS, et al
    Computerized margin and texture analyses for differentiating bacterial pneumonia and invasive mucinous adenocarcinoma presenting as consolidation.
    PLoS One. 2017;12:e0177379.
    PubMed     Text format     Abstract available

  31. ZHAO XK, Mao YM, Meng H, Song X, et al
    Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern China.
    PLoS One. 2017;12:e0177504.
    PubMed     Text format     Abstract available

  32. FARQUHAR M, Penfold C, Benson J, Lovick R, et al
    Six key topics informal carers of patients with breathlessness in advanced disease want to learn about and why: MRC phase I study to inform an educational intervention.
    PLoS One. 2017;12:e0177081.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: